Success Metrics

Clinical Success Rate
42.9%

Based on 3 completed trials

Completion Rate
43%(3/7)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
4(50%)

Phase Distribution

Ph phase_1
1
13%
Ph phase_2
7
88%

Phase Distribution

1

Early Stage

7

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
7(87.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

42.9%

3 of 7 finished

Non-Completion Rate

57.1%

4 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(3)
Terminated(4)
Other(1)

Detailed Status

Terminated4
Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
42.9%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (12.5%)
Phase 27 (87.5%)

Trials by Status

completed338%
terminated450%
unknown113%

Recent Activity

0 active trials
Showing 5 of 8
terminatedphase_1

Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema

NCT01194674
completedphase_2

Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke

NCT00123305
terminatedphase_2

Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT

NCT00428129
completedphase_2

Safety and Efficacy Study of Microplasmin in for Non-Surgical Treatment of Focal Vitreomacular Adhesion

NCT01055535
terminatedphase_2

Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion

NCT00123292
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT01194674Phase 1

Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema

Terminated
NCT00123305Phase 2

Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke

Completed
NCT00428129Phase 2

Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT

Terminated
NCT01055535Phase 2

Safety and Efficacy Study of Microplasmin in for Non-Surgical Treatment of Focal Vitreomacular Adhesion

Completed
NCT00123292Phase 2

Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion

Terminated
NCT00123266Phase 2

Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion

Terminated
NCT00123279Phase 2

Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy

Completed
NCT00996684Phase 2

Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8